Developing a Novel Indolocarbazole as Histone Deacetylases Inhibitor against Leukemia Cell Lines

Figure 5

Effects of ZW2-1 on CD11b, CD14, and CD38 expression. Flow cytometric analysis of expression of CD11b and CD14 at 0, 48, and 72 hr after treatment with ZW2-1, respectively, and expression of CD38 at 0, 6, and 12 hr after treatment with ZW2-1. To measure the percent positive signal, control group was set to exclude about 95% of the live cell population peak. All experiments are presented as mean ± SD of three independent experiments performed in replicates.